Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck von Ferris, Robert L, Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E, Even, Caroline, Worden, Francis, Saba, Nabil F, Iglesias Docampo, Lara C, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Geese, William J, Kopit, Justin, Shaw, James W, Gillison, Maura L

Volltext

SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets von Freiberger, Sandra N., Brada, Muriel, Fritz, Christine, Höller, Sylvia, Vogetseder, Alexander, Horcic, Milo, Bihl, Michel, Michal, Michal, Lanzer, Martin, Wartenberg, Martin, Borner, Urs, Bode, Peter K., Broglie, Martina A., Rordorf, Tamara, Morand, Grégoire B., Rupp, Niels J.

Volltext

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck von Ferris, Robert L., Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Iglesias Docampo, Lara C., Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Geese, William J., Kopit, Justin, Shaw, James W., Gillison, Maura L.

Volltext

KEYNOTE-048: Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic... von Harrington, Kevin Joseph, Rischin, Danny, Greil, Richard, Soulieres, Denis, Tahara, Makoto, Castro, Gilberto, Psyrri, Amanda, Baste, Neus, Neupane, Prakash C., Bratland, Åse, Fuereder, Thorsten, Hughes, Brett Gordon Maxwell, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Zhang, Yayan, Gumuscu, Burak, Swaby, Ramona F., Burtness, Barbara

Volltext

Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R... von Rischin, Danny, Harrington, Kevin J., Greil, Richard, Soulieres, Denis, Tahara, Makoto, de Castro, Gilberto, Psyrri, Amanda, Baste, Neus, Neupane, Prakash C., Bratland, Ase, Fuereder, Thorsten, Hughes, Brett Gordon Maxwell, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Zhang, Yayan, Jin, Fan, Gumuscu, Burak, Burtness, Barbara

Volltext

Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget’s disease von Nordmann, Thierry M., Messerli-Odermatt, Olivia, Meier, Larissa, Micaletto, Sara, Coppetti, Thomas, Nägeli, Mirjam, Kamarachev, Jivko, Kudura, Ken, Freiberger, Sandra N., Rordorf, Tamara, Mangana, Joanna, Braun, Ralph, Dummer, Reinhard

Volltext

18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study von Schneider, Paul M, Eshmuminov, Dilmurodjon, Rordorf, Tamara, Vetter, Diana, Veit-Haibach, Patrick, Weber, Achim, Bauerfeind, Peter, Samaras, Panagiotis, Lehmann, Kuno

Volltext

Nivolumab (Nivo) vs investigator’s choice (IC) for platinum-refractory (PR) recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN; Checkmate 141): Outco... von Gillison, Maura L., Blumenschein, George R., Fayette, Jérôme, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis P., Saba, Nabil F., Iglesias Docampo, Lara Carmen, Haddad, Robert I., Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Lynch, Mark John, Kopit, Justin, Ferris, Robert L.

Volltext

Abstract CT099: Nivolumab (nivo) vs investigator's choice (IC) for recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): CheckMate-141 von Gillison, Maura L., Blumenschein, George, Fayette, Jérôme, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Iglesias Docampo, Lara Carmen, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Geese, William J., Schactman, Mark, Kopit, Justin, Shaw, James W., Ferris, Robert L.

Volltext

Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer von Studer, Gabriela, Rordorf, Tamara, Glanzmann, Christoph

Volltext

Follow up after IMRT in oral cavity cancer: update von Studer, Gabriela, Brown, Michelle, Bredell, Marius, Graetz, Klaus W, Huber, Gerhard, Linsenmeier, Claudia, Najafi, Yousef, Riesterer, Oliver, Rordorf, Tamara, Schmid, Stephan, Glanzmann, Christoph

Volltext

Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study von Bredell, Marius, Rordorf, Tamara, Kroiss, Sabine, Rücker, Martin, Zweifel, Daniel Fritz, Rostetter, Claudio

Volltext

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study von Harrington, Kevin J, Burtness, Barbara, Greil, Richard, Soulières, Denis, Tahara, Makoto, de Castro, Jr, Gilberto, Psyrri, Amanda, Brana, Irene, Basté, Neus, Neupane, Prakash, Bratland, Åse, Fuereder, Thorsten, Hughes, Brett G M, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Lin, Jianxin, Gumuscu, Burak, Swaby, Ramona F, Rischin, Danny

Volltext

Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor... von Ferris, Robert L., Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin J., Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Docampo, Lara Carmen Iglesias, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Lynch, Mark, Jayaprakash, Vijayvel, Li, Li, Gillison, Maura L.

Volltext

Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit von Yu, Jinghua, Zhang, Yitao, McIlroy, James, Rordorf-Nikolic, Tamara, Orr, George A., Backer, Jonathan M.

Volltext

Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Posi... von Burtness, Barbara, Rischin, Danny, Greil, Richard, Soulières, Denis, Tahara, Makoto, de Castro, Jr, Gilberto, Psyrri, Amanda, Brana, Irene, Basté, Neus, Neupane, Prakash, Bratland, Åse, Fuereder, Thorsten, Hughes, Brett G M, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Ge, Joy, Swaby, Ramona F, Gumuscu, Burak, Harrington, Kevin

Volltext

IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes von Satoh, Takashi K., Mellett, Mark, Meier-Schiesser, Barbara, Fenini, Gabriele, Otsuka, Atsushi, Beer, Hans-Dietmar, Rordorf, Tamara, Maul, Julia-Tatjana, Hafner, Jurg, Navarini, Alexander A., Contassot, Emmanuel, French, Lars E.

Volltext

CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer von Gillison, Maura L., Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin J., Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Iglesias Docampo, Lara Carmen, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Li, Li, Ferris, Robert L.

Volltext

Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141 von Gillison, Maura L, Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A Dimitrios, Licitra, Lisa, Harrington, Kevin J, Kasper, Stefan, Vokes, Everett E, Even, Caroline, Worden, Francis, Saba, Nabil F, Iglesias Docampo, Lara Carmen, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Jayaprakash, Vijayvel, Wei, Li, Ferris, Robert L

Volltext

Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study von Harrington, Kevin J, Burtness, Barbara, Greil, Richard, Soulières, Denis, Tahara, Makoto, Castro, Gilberto de, Psyrri, Amanda, Braña, Irene, Basté, Neus, Neupane, Prakash, Bratland, Åse, Fuereder, Thorsten, Hughes, Brett G.M, Mesía Nin, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Ishak, Wan Zamaniah Wan, Lin, Jiaxin, Gumuscu, Burak, Swaby, Ramona F, Rischin, Danny

Volltext